Therapeutic Area
Infectious Disease
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
The Lancet
Infectious Disease
Benzylpenicillin versus flucloxacillin or cloxacillin for the treatment of penicillin-susceptible Staphylococcus aureus bacteraemia (SNAP): an international, multicentre, open-label, non-inferiority randomised controlled trial
July 9, 2026
10.1016/S0140-6736(26)00761-0
The New England Journal of Medicine
Infectious Disease
Cefazolin versus Cloxacillin or Flucloxacillin for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Randomized Clinical Trial
June 17, 2026
10.1056/NEJMoa2506905
JAMA Network Open
Sepsis
Infectious Disease
Remote Monitoring Approaches to Reduce Readmissions After Infection and Sepsis: A Randomized Clinical Trial
June 11, 2026
doi:10.1001/jamanetworkopen.2026.16641
The New England Journal of Medicine
COVID-19
Infectious Disease
Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients
April 22, 2026
doi: 10.1056/NEJMoa2502457
BMJ Journals
Infectious Disease
Is there a role for anticoagulation with dabigatran in S. aureus bacteremia? Protocol for the adjunctive treatment domain of the Staphylococcus aureus Network Adaptive Platform (SNAP) randomised controlled trial
December 12, 2025
DOI: 10.1136/bmjopen-2025-107493
BMJ Journals
Infectious Disease
Platform
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
July 15, 2025
DOI: 10.1136/thorax-2024-222488
Springer Nature
Infectious Disease
Meta-analysis
Corticosteroids for adult patients hospitalised with non-viral community-acquired pneumonia: a systematic review and meta-analysis
May 5, 2025
DOI:10.1007/s00134-025-07912-2
Springer Nature
Infectious Disease
Platform
Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial
April 22, 2025
DOI: 10.1007/s00134-025-07861-w
The Journal of Infectious Diseases
COVID-19
Infectious Disease
A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration
April 1, 2025
doi.org/10.1093/infdis/jiaf158
Springer Nature
Infectious Disease
Platform
Statistical documentation for multi-disease, multi-domain platform trials: our experience with the Staphylococcus aureus Network Adaptive Platform trial
February 11, 2025
DOI: 10.1186/s13063-024-08684-8
Annals of Internal Medicine
Infectious Disease
Meta-analysis
Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis
January 17, 2025
DOI: 10.7326/ANNALS-24-00800
Trials Journal
Infectious Disease
Platform
A blueprint for a multi-disease, multi-domain Bayesian adaptive platform trial incorporating adult and paediatric subgroups: the Staphylococcus aureus Network Adaptive Platform trial
December 6, 2024
doi: 10.1186/s13063-023-07718-x.